MedPath

ature experience-based virtual reality improves depressive symptoms in a young population: A pilot study

Not Applicable
Completed
Conditions
Mental and behavioural disorders
Registration Number
KCT0009142
Lead Sponsor
Jungwon University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion criteria were no history of previous diagnosis, no depression treatment of any type, score higher than 14 on the Korean version of the Beck Depression Inventory (K-BDI)-II, and age between 20 and 50 years.

Exclusion Criteria

Exclusion criteria were age under 20 years; heavy alcohol use; history of seizures or epilepsy in VR; or use of devices such as a pacemaker, hearing aids, or defibrillator. Subjects older than 50 years were excluded because they are more susceptible to VR sickness than younger users. People who have experienced undesirable symptoms, such dizziness or headaches, when using an HMD with VR technology were also excluded.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of a virtual reality-based meditation program for depression improvement and evaluation of effectiveness through clinical trials.
Secondary Outcome Measures
NameTimeMethod
Differences between Korean Beck Depression Inventory (K-BDI)-II questionnaires administered before and after starting VR viewing;Differences in levels of free brain-derived neurotrophic factor (BDNF), cortisol, and interleukin-6 (IL-6) measured before and after starting VR viewing. ?
© Copyright 2025. All Rights Reserved by MedPath